KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 72 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 1.04 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,401,000 | 0.0% | 153,449 | 0.0% | 0.62% | +3.7% |
| Q4 2018 | $1,401,000 | -19.7% | 153,449 | +50.4% | 0.60% | +0.2% |
| Q3 2018 | $1,744,000 | +2135.9% | 102,006 | +774.7% | 0.60% | +1516.2% |
| Q2 2016 | $78,000 | -25.0% | 11,662 | 0.0% | 0.04% | -26.0% |
| Q1 2016 | $104,000 | -32.9% | 11,662 | 0.0% | 0.05% | -32.4% |
| Q4 2015 | $155,000 | +26.0% | 11,662 | 0.0% | 0.07% | +19.4% |
| Q3 2015 | $123,000 | -61.2% | 11,662 | 0.0% | 0.06% | -56.9% |
| Q2 2015 | $317,000 | -11.2% | 11,662 | 0.0% | 0.14% | -11.7% |
| Q1 2015 | $357,000 | +149.7% | 11,662 | +205.4% | 0.16% | +143.3% |
| Q4 2014 | $143,000 | +7.5% | 3,819 | 0.0% | 0.07% | – |
| Q3 2014 | $133,000 | -25.3% | 3,819 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $178,000 | – | 3,819 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |